Philip Frost - Opko Health Chairman of the Board, CEO
| OPK Stock | USD 1.23 0.02 1.60% |
Chairman
Dr. Phillip Frost M.D. serves as Chairman of the Board Chief Executive Officer of OPKO Health Inc. since March 2007. He was named Chairman of the Board of Ladenburg Thalmann Financial Services Inc. an investment banking asset management and securities brokerage firm providing services through its principal operating subsidiary Ladenburg Thalmann Co. Inc. in July 2006 and was a director of Ladenburg Thalmann from 2001 until 2002 and again since 2004. He is Vice Chairman of IDI Inc. an information solutions provider focused on the datafusion market and a director for each of Castle Brands a developer and marketer of premium brand spirits Cocrystal Pharma Inc. a publicly traded biotechnology company developing new treatments for viral diseases and Sevion Therapeutics Inc. a clinical stage company which discovers and develops nextgeneration biologics for the treatment of cancer and immunological diseases. He serves as a member of the Board of Trustees of the University of Miami the Skolkovo Foundation Scientific Advisory Council in Russia the Shanghai Institute for Advanced Immunochemical Studies in China and The Florida Council of 100 and as a Trustee of each of the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. Dr. Frost served as a director of Teva Pharmaceutical Industries Limited or Teva from January 2006 until February 2015 and had served as Chairman of the Board of Teva from March 2010 until December 2014 and as Vice Chairman from January 2006 until March 2010. Dr. Frost previously served as a director for Continucare Corporation TransEnterix Inc. SafeStitch Medical Inc. prior to its merger with TransEnterix Inc. and PROLOR Biotech Inc. prior to its acquisition by the Company in August 2013 as Governor and CoVice Chairman of the American Stock Exchange and as a member of the Board of Trustees of the Scripps Research Institute until November 2012. since 2007.
| Age | 78 |
| Tenure | 17 years |
| Address | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 |
| Phone | 305 575 4100 |
| Web | https://www.opko.com |
Opko Health Management Efficiency
The company has Return on Asset of (0.0473) % which means that on every $100 spent on assets, it lost $0.0473. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.128) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.41. The value of Return On Capital Employed is expected to slide to -0.09. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Change To Liabilities is expected to rise to 0.00 this year, although the value of Total Current Liabilities will most likely fall to about 103.9 M.Similar Executives
| Found 11 records | CHAIRMAN Age | ||
| Boon Koh | Agilent Technologies | 70 | |
| Jay Flatley | Illumina | 65 | |
| Daniel Bradbury | Castle Biosciences | 57 | |
| Mats Olsson | 23Andme Holding Co | 63 | |
| Giovanni Lettieri | 23Andme Holding Co | 58 | |
| Ming Hsieh | Fulgent Genetics | 68 | |
| James Cullen | Agilent Technologies | 72 | |
| William Rastetter | Illumina | 66 | |
| Matthew Rabinowitz | Natera Inc | 51 | |
| Jonathan Ayers | IDEXX Laboratories | 61 | |
| Michael Goldberg | Caredx Inc | 60 | |
Management Performance
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0473 |
Opko Health Leadership Team
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arie Gutman, Pres API | ||
| Dr MBA, Vice Officer | ||
| FACP FASN, Senior Renal | ||
| David Okrongly, President Diagnostics | ||
| Antonio Cruz, President Therapeutics | ||
| Dmitry Kolosov, Independent Director | ||
| Richard Lerner, Independent Director | ||
| Thomas Nusbickel, Chief Commercial Officer of the Company's Renal Division | ||
| Elias MD, President Chairman | ||
| Richard Pfenniger, Independent Director | ||
| Philip Frost, Chairman of the Board, CEO | ||
| Thomas Beier, Director | ||
| Akhtar Ashfaq, Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division | ||
| Jon Cohen, Executive Chairman of BioReference Laboratories | ||
| Robert Fishel, Independent Director | ||
| Robert Baron, Independent Director | ||
| Anne Fields, IR Contact Officer | ||
| Adam Logal, CFO, Chief Accounting Officer, Sr. VP and Treasurer | ||
| Alice Yu, Independent Director | ||
| Steven Rubin, Executive Vice President - Administration, Director | ||
| JD Esq, Chief Laboratories | ||
| Charles Bishop, Chief Renal | ||
| Hans Berner, President Iberoamerica | ||
| James DeMarco, VP Sales | ||
| John Paganelli, Independent Director | ||
| Phillip Frost, Chairman of the Board, CEO | ||
| Miriam Miller, IR Contact Officer | ||
| MBA MBA, Vice Officer | ||
| Jon MD, Advisor | ||
| Jane Hsiao, Vice Chairman of the Board, Chief Technical Officer | ||
| Geoff Monk, President of BioReference | ||
| Richard Krasno, Independent Director |
Opko Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Opko Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0473 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 1.09 B | ||||
| Shares Outstanding | 696.99 M | ||||
| Shares Owned By Insiders | 52.40 % | ||||
| Shares Owned By Institutions | 25.05 % | ||||
| Number Of Shares Shorted | 93.61 M | ||||
| Price To Earning | 7.46 X |
Opko Health Investors Sentiment
The influence of Opko Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Opko. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Opko Health's public news can be used to forecast risks associated with an investment in Opko. The trend in average sentiment can be used to explain how an investor holding Opko can time the market purely based on public headlines and social activities around Opko Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Opko Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Opko Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Opko Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Opko Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Opko Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Opko Health's short interest history, or implied volatility extrapolated from Opko Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Opko Stock analysis
When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Opko Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.25) | Revenue Per Share 1.149 | Quarterly Revenue Growth (0.02) | Return On Assets (0.05) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.